Page 80 - Read Online
P. 80

Page 32 of 35               Boyajian et al. Microbiome Res Rep 2024;3:29  https://dx.doi.org/10.20517/mrr.2024.05

               150.      Mohammed I, Hollenberg MD, Ding H, Triggle CR. A critical review of the evidence that metformin is a putative anti-aging drug
                    that enhances healthspan and extends lifespan. Front Endocrinol 2021;12:718942.  DOI  PubMed  PMC
               151.      Campbell JM, Bellman SM, Stephenson MD, Lisy K. Metformin reduces all-cause mortality and diseases of ageing independent of its
                    effect on diabetes control: a systematic review and meta-analysis. Ageing Res Rev 2017;40:31-44.  DOI  PubMed
               152.      U.S. Food and Drug Administration. GLUCOPHAGE® (metformin hydrochloride) tablets. Available from: https://www.accessdata.
                    fda.gov/drugsatfda_docs/label/2017/020357s037s039,021202s021s023lbl.pdf. [Last accessed on 15 May 2024].
               153.      LaMoia TE, Shulman GI. Cellular and molecular mechanisms of metformin action. Endocr Rev 2021;42:77-96.  DOI  PubMed  PMC
               154.      Kulkarni AS, Brutsaert EF, Anghel V, et al. Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and
                    subcutaneous adipose tissues of older adults. Aging Cell 2018;17:e12723.  DOI  PubMed  PMC
               155.      U.S. Food and Drug Administration. Rapamune (sirolimus) Label. Highlights of prescribing information. Available from: https://
                    www.accessdata.fda.gov/drugsatfda_docs/label/2017/021083s059,021110s076lbl.pdf. [Last accessed on 15 May 2024].
               156.      Juricic P, Lu YX, Leech T, et al. Long-lasting geroprotection from brief rapamycin treatment in early adulthood by persistently
                    increased intestinal autophagy. Nat Aging 2022;2:824-36.  DOI  PubMed  PMC
               157.      Kulkarni AS, Aleksic S, Berger DM, Sierra F, Kuchel GA, Barzilai N. Geroscience-guided repurposing of FDA-approved drugs to
                    target aging: A proposed process and prioritization. Aging Cell 2022;21:e13596.  DOI  PubMed  PMC
               158.      Ershad M, Naji A, Vearrier D. N-acetylcysteine. Treasure island (FL): StatPearls Publishing; 2024.  PubMed
               159.      Sohouli MH, Eslamian G, Malekpour Alamdari N, et al. Effects of N-acetylcysteine on aging cell and obesity complications in obese
                    adults: a randomized, double-blind clinical trial. Front Nutr 2023;10:1237869.  DOI  PubMed  PMC
                                                 TM
               160.      U.S. Food and Drug Administration. Sprycel  (dasatinib) tablets. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/
                    nda/2006/021986s000_Sprycel__PRNTLBL.pdf. [Last accessed on 15 May 2024].
               161.      Zhang L, Pitcher LE, Yousefzadeh MJ, Niedernhofer LJ, Robbins PD, Zhu Y. Cellular senescence: a key therapeutic target in aging
                    and diseases. J Clin Invest 2022;132:e158450.  DOI  PubMed  PMC
               162.      Scarpellini E, Rinninella E, Basilico M, et al. From pre- and probiotics to post-biotics: a narrative review. Int J Environ Res Public
                    Health 2021;19:37.  DOI  PubMed  PMC
               163.      Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients 2013;5:1417-35.  DOI  PubMed  PMC
               164.      Green M, Arora K, Prakash S. Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome.
                    Int J Mol Sci 2020;21:2890.  DOI  PubMed  PMC
               165.      Davani-Davari D, Negahdaripour M, Karimzadeh I, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications.
                    Foods 2019;8:92.  DOI  PubMed  PMC
               166.      Canfora EE, van der Beek CM, Hermes GDA, et al. Supplementation of diet with galacto-oligosaccharides increases bifidobacteria,
                    but not insulin sensitivity, in obese prediabetic individuals. Gastroenterology 2017;153:87-97.e3.  DOI  PubMed
               167.      Arnold JW, Roach J, Fabela S, et al. The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut. Microbiome
                    2021;9:31.  DOI  PubMed  PMC
               168.      Qiang X, Yonglie C, Qianbing W. Health benefit application of functional oligosaccharides. Carbohydr Polym 2009;77:435-41.  DOI
               169.      Ma C, Yang K, Wang Y, Dai X. Anti-aging effect of agar oligosaccharide on male drosophila melanogaster and its preliminary
                    mechanism. Mar Drugs 2019;17:632.  DOI  PubMed  PMC
               170.      D’Andrea G. Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia 2015;106:256-71.  DOI  PubMed
               171.      Jung CH, Cho I, Ahn J, Jeon TI, Ha TY. Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid
                    metabolism genes. Phytother Res 2013;27:139-43.  DOI  PubMed
               172.      Cui Z, Zhao X, Amevor FK, et al. Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism.
                    Front Immunol 2022;13:943321.  DOI  PubMed  PMC
               173.      Saccon TD, Nagpal R, Yadav H, et al. Senolytic combination of dasatinib and quercetin alleviates intestinal senescence and
                    inflammation and modulates the gut microbiome in aged mice. J Gerontol A Biol Sci Med Sci 2021;76:1895-905.  DOI  PubMed
                    PMC
               174.      Gonzales MM, Garbarino VR, Marques Zilli E, et al. Senolytic therapy to modulate the progression of Alzheimer’s disease (SToMP-
                    AD): a pilot clinical trial. J Prev Alzheimers Dis 2022;9:22-9.  DOI  PubMed  PMC
               175.      Zhao L, Zhu X, Xia M, et al. Quercetin ameliorates gut microbiota dysbiosis that drives hypothalamic damage and hepatic
                    lipogenesis in monosodium glutamate-induced abdominal obesity. Front Nutr 2021;8:671353.  DOI  PubMed  PMC
               176.      Shi T, Bian X, Yao Z, Wang Y, Gao W, Guo C. Quercetin improves gut dysbiosis in antibiotic-treated mice. Food Funct
                    2020;11:8003-13.  DOI
               177.      Yuan H, Li Y, Ling F, et al. The phytochemical epigallocatechin gallate prolongs the lifespan by improving lipid metabolism,
                    reducing inflammation and oxidative stress in high-fat diet-fed obese rats. Aging Cell 2020;19:e13199.  DOI  PubMed  PMC
               178.      Huang LH, Liu CY, Wang LY, Huang CJ, Hsu CH. Effects of green tea extract on overweight and obese women with high levels of
                    low density-lipoprotein-cholesterol (LDL-C): a randomised, double-blind, and cross-over placebo-controlled clinical trial. BMC
                    Complement Altern Med 2018;18:294.  DOI  PubMed  PMC
               179.      D'Amico D, Olmer M, Fouassier AM, et al. Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates
                    pain in osteoarthritis. Aging Cell 2022;21:e13662.  DOI  PubMed  PMC
               180.      Kong S, Huang X, Cao H, et al. Anti-obesity effects of galacto-oligosaccharides in obese rats. Eur J Pharmacol 2022;917:174728.
                    DOI
   75   76   77   78   79   80   81   82   83   84   85